Scancell Share Discussion Threads

[chilltime] 14/6/2024 07:32

Sci

A number have had a complete response FACT.


You are a frustrated hype investor, frustrated that they won’t keep pushing out updates.

If like many, there is an annoying noise around home about your investment choices, so you sound off at everyone else and harass Scancell.

[chilltime] 14/6/2024 07:27

What you have done fella is call specific people liars on a public site, and then post exact email content that you sent to them.

A host of name calling indicating others post primary school style……… brilliant😂😂😂

[sci102] 14/6/2024 07:23

Hey Bermuda, mr expert lmao. Wanna give your opinion on that nonsense, after all you'd be replying to CIT (much closer to your level), not me.

[chilltime] 14/6/2024 07:13

I’ve popped on here due to the Lindy interview.

The last official update gave the ORR as 85%, with a success rate (70% target) as 90% likely.

Since that time repeated posters and presentations, keep to 85%.

Reading between the lines it tells me, 85% is holding strong, if it wasn’t the material changes would require an RNS.

So what we have is that interview. Rumour control via various forums including cancer forums indicated that complete responses for Scib are increasing, I was guessing about 4-5.

In the interview Lindy says ‘some’ complete responses. Some definition is more than 2, so I’m happy to take a guess at 3-5 complete responses so far.

Given that the first 4 saw something like 80% shrinkage in quick time, 3-5 seems like a safe bet.

Logic dictates that’s likely to be the early patients, 3 or 5 of 13.

Either way, in the AIM private investor world, that’s knock your socks off, holy grail, multi billion etc etc, 1000’s of retail investors piling in. But they don’t know, they are oblivious.


Lindy sounded very confident, whatever data they have clearly has her believing the eureka moment has arrived (privately), but they are waiting for the data to hit it’s endpoints to shout publicly about it. She dropped hints and is clearly excited (in Lindy terms). She is a very level-headed grounded character

If 85% has been maintained then the 90% probability will have been rising.

Small caps are falling apart. Investors are crying out for a good news share, they are chasing junk due to the lack of good prospects.

The shouting and flag waving will come along with the investors.

The interest in Scib from majors will be growing fast. Lindy is already saying, if they don’t offer a good enough deal we’ll go it alone.

If you recall what she said a while back, there are a number of interested parties in the background, ready to splash the cash when the timing (data/progress) is right).

That’s why she is confident enough to say such things.

[sci102] 14/6/2024 07:06

I have put forward specific facts and asked specific questions, how about discuss those, if you can, instead of writting primary school level drivel?

[chilltime] 14/6/2024 06:47

Just popped on to have a look, 844 posts missed, 84.4% which appear to be nonsense. Please feel free to go through the last 844 to clarify my percentage findings

Sci

You appear to be an AIM trader, hoping for an AIM type company/CEO here.

I too was frustrated by the lack of updates, probably due to being conditioned by the majority of small caps who pump out regular news.

However, I was quick to learn on Scancell, that Lindy is a dedicated scientist determined to progress treatment of csncer, NOT a typical AIM CEO focussed on retail investors hunger for news.

News to create volume and share price movements.

Scancell does not have a retail herd following as a result of the lack of flag waving.

Others do have a retail crowd following them, the volume and share price moves are regular, usually due to regular pump news by over-exuberant CEOs. Near all have been decimated, many bust.


Lindy has said she will shout when she has something to shout about.

In AIM terms, for AIM conditioned investors an 85% response rate should be plastered all over social media with 1000’s of retail piling in and a market cap of £600m plus now.

The thread would be full of nutters calling £50 per share etc. They do that on Scancell fraction of what Scancell are actually achieving.


If you are experienced in the stock market as you claim, then you should know that.

[sci102] 13/6/2024 17:21

"Expert" 😅😅😅😅8517;

[sci102] 13/6/2024 17:07

And also about the mysterious case of the "failed screenings" disappearance㈳7;

[sci102] 13/6/2024 17:05

Hello Bermuda.

I can't wait to read your essay about how Lindy is absolutely correct that scib1 recruitment has been slow because patients have been waiting for iscib1+ 😅

[bermudashorts] 13/6/2024 16:58

marcus -

Simon?

[sci102] 13/6/2024 16:21

Also at the 8min mark she said the BS about patients not opting for scib1 because they were waiting for iscib1+.
She also let everyone believe that there are now multiple complete responses, I suspect more BS but hopefully not.

At least she put the BS that they would seek accelerated approval as soon as phase 3 starts to rest.

[sci102] 13/6/2024 16:18

She did not confirm. She repeated the November results. Big difference.

[ruckrover] 13/6/2024 16:15

Marcus, et al, The video link was posted by pharmaboy yesterday. Unfortunately it seems to have got lost in the noise and squabbles. Maybe people will now sit up and take notice, it is a very significant interview as it addresses much of the speculation tossed around on these boards. 8:38 interviewer - what are the plans for the vaccines? Sell to big pharma?8.53 LD - you never plan to sell out to big pharma. The plan is to take the vaccines (plural, SCIB1 and MODI1) through phase 2/3 trials all the way through to approval. Of course, if a big pharma made an attractive offer it woul be considered. So this allays the fear that Scancell will be bought on the cheap. It also implies that the BOD have the full backing of Redmile and Vulpes in this plan.Other comments of interest from LD....ISCIB+ has an 18 year patent period. All the science is well protected by patents. She described SCIB1 as having produced "stunning results" She confirmed the 85% ORR. She stated that it is hoped funding will in part come from deals so the worry of dilution is "partially de-risked". She did not rule out other funding options. It is worth noting that the video was posted yesterday so the interview is very recent presumably? Hopefully this will satisfy those clamouring for updates.

[countbruga] 13/6/2024 14:51

Lozan,
I can tell you've finally figured out how to work Caps Lock. Progress, well done!

[marcusl2] 13/6/2024 14:48

Scancell
@scancellpharma
·
42m
Check out an insightful interview with our CEO, Lindy Durrant and
@_focusIR_
, during which Lindy discusses Scancell’s pipeline, clinical data and deals with big pharma.

[the real lozan] 13/6/2024 14:36

Straight from the '£8 a share' evidence book -
"The narcissist doesn't own any shares and is definitely foreign.
Maybe someone who was either previously employed or didn't get a job they wanted at Scancell."
.
Perhaps, using the same unquestioning logic, could you tell everyone =
How tall she is ???

[countbruga] 13/6/2024 13:15

The narcissist doesn't own any shares and is definitely foreign.
Maybe someone who was either previously employed or didn't get a job they wanted at Scancell.

[inanaco] 13/6/2024 12:33

and the share moves away from you ......... do you have any money SC >

[sci102] 13/6/2024 11:59

Funny how you suggest spelling might indicate something and you ignore what the CEO/CFO/RNS say and how they contradict themselves, Sherlock 😅

[sci102] 13/6/2024 11:54

Smelly smelly. Anything to say to the point?

[markingtime] 13/6/2024 11:50

Interesting.....American spelling from our resident cuckoo.......mmmmm.....

[countbruga] 13/6/2024 11:26

The childish clocksucker is at it again.